Study into conolidine has led to discovery of the opioid receptor in the body identified as ACKR3/CXCR7. ACKR3 appears to be probably the most sought after target for conolidine, which also disregards the opposite 4 classical opioid receptors(3). thank you.. A: There is limited details on contraindications in between https://oliverg627epw7.corpfinwiki.com/user